Various organocatalysts are developed to accelerate the carbon dioxide utilisation as feedstock to value-added organic chemicals synthesis with silanes as strategic reducing agents.
No takes yet. Share an insight, caveat, or question.
Pramudita et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: